These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 26799241)
1. Organometallic Rhenium Complexes Divert Doxorubicin to the Mitochondria. Imstepf S; Pierroz V; Rubbiani R; Felber M; Fox T; Gasser G; Alberto R Angew Chem Int Ed Engl; 2016 Feb; 55(8):2792-5. PubMed ID: 26799241 [TBL] [Abstract][Full Text] [Related]
2. Towards cancer cell-specific phototoxic organometallic rhenium(I) complexes. Leonidova A; Pierroz V; Rubbiani R; Heier J; Ferrari S; Gasser G Dalton Trans; 2014 Mar; 43(11):4287-94. PubMed ID: 23982882 [TBL] [Abstract][Full Text] [Related]
3. Mono- and Dinuclear Phosphorescent Rhenium(I) Complexes: Impact of Subcellular Localization on Anticancer Mechanisms. Ye RR; Tan CP; Chen MH; Hao L; Ji LN; Mao ZW Chemistry; 2016 Jun; 22(23):7800-9. PubMed ID: 27106876 [TBL] [Abstract][Full Text] [Related]
4. Underestimated potential of organometallic rhenium complexes as anticancer agents. Leonidova A; Gasser G ACS Chem Biol; 2014 Oct; 9(10):2180-93. PubMed ID: 25137157 [TBL] [Abstract][Full Text] [Related]
5. Towards (99m)Tc-based imaging agents with effective doxorubicin mimetics: a molecular and cellular study. Imstepf S; Pierroz V; Raposinho P; Felber M; Fox T; Fernandes C; Gasser G; Santos IR; Alberto R Dalton Trans; 2016 Aug; 45(33):13025-33. PubMed ID: 27097328 [TBL] [Abstract][Full Text] [Related]
6. Labeling of proteins by organometallic complexes of rhenium. (I). Synthesis and biological activity of the conjugates. Salmain M; Gunn M; Gorfti A; Top S; Jaouen G Bioconjug Chem; 1993; 4(6):425-33. PubMed ID: 8305511 [TBL] [Abstract][Full Text] [Related]
7. A phosphorescent rhenium(I) histone deacetylase inhibitor: mitochondrial targeting and paraptosis induction. Ye RR; Tan CP; Lin YN; Ji LN; Mao ZW Chem Commun (Camb); 2015 May; 51(39):8353-6. PubMed ID: 25882790 [TBL] [Abstract][Full Text] [Related]
8. Apoptosis repressor with caspase recruitment domain contributes to chemotherapy resistance by abolishing mitochondrial fission mediated by dynamin-related protein-1. Wang JX; Li Q; Li PF Cancer Res; 2009 Jan; 69(2):492-500. PubMed ID: 19147562 [TBL] [Abstract][Full Text] [Related]
9. A deadly organometallic luminescent probe: anticancer activity of a ReI bisquinoline complex. Kitanovic I; Can S; Alborzinia H; Kitanovic A; Pierroz V; Leonidova A; Pinto A; Spingler B; Ferrari S; Molteni R; Steffen A; Metzler-Nolte N; Wölfl S; Gasser G Chemistry; 2014 Feb; 20(9):2496-507. PubMed ID: 24464824 [TBL] [Abstract][Full Text] [Related]
10. Influence of the metal center and linker on the intracellular distribution and biological activity of organometal-peptide conjugates. Hu W; Splith K; Neundorf I; Merz K; Schatzschneider U J Biol Inorg Chem; 2012 Feb; 17(2):175-85. PubMed ID: 21898043 [TBL] [Abstract][Full Text] [Related]
11. Luminescent Rhenium(I) and Iridium(III) Polypyridine Complexes as Biological Probes, Imaging Reagents, and Photocytotoxic Agents. Lo KK Acc Chem Res; 2015 Dec; 48(12):2985-95. PubMed ID: 26161527 [TBL] [Abstract][Full Text] [Related]
12. Anticancer and Antibiotic Rhenium Tri- and Dicarbonyl Complexes: Current Research and Future Perspectives. Schindler K; Zobi F Molecules; 2022 Jan; 27(2):. PubMed ID: 35056856 [TBL] [Abstract][Full Text] [Related]
13. Targeted delivery of doxorubicin to mitochondria. Chamberlain GR; Tulumello DV; Kelley SO ACS Chem Biol; 2013 Jul; 8(7):1389-95. PubMed ID: 23590228 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of rhenium(I) alkoxo and hydroxo carbonyl complexes in murine and human tumor cells. Yan YK; Cho SE; Shaffer KA; Rowell JE; Barnes BJ; Hall IH Pharmazie; 2000 Apr; 55(4):307-13. PubMed ID: 10798247 [TBL] [Abstract][Full Text] [Related]
15. Rhenium(I) polypyridine dibenzocyclooctyne complexes as phosphorescent bioorthogonal probes: Synthesis, characterization, emissive behavior, and biolabeling properties. Choi AW; Liu HW; Lo KK J Inorg Biochem; 2015 Jul; 148():2-10. PubMed ID: 25798989 [TBL] [Abstract][Full Text] [Related]
16. Toward hypoxia-selective rhenium and technetium tricarbonyl complexes. North AJ; Hayne DJ; Schieber C; Price K; White AR; Crouch PJ; Rigopoulos A; O'Keefe GJ; Tochon-Danguy H; Scott AM; White JM; Ackermann U; Donnelly PS Inorg Chem; 2015 Oct; 54(19):9594-610. PubMed ID: 26375592 [TBL] [Abstract][Full Text] [Related]
17. Design of Rhenium Compounds in Targeted Anticancer Therapeutics. Collery P; Desmaele D; Vijaykumar V Curr Pharm Des; 2019; 25(31):3306-3322. PubMed ID: 31475892 [TBL] [Abstract][Full Text] [Related]
18. Cellular uptake and cytotoxicity of octahedral rhenium cluster complexes. Choi SJ; Brylev KA; Xu JZ; Mironov YV; Fedorov VE; Sohn YS; Kim SJ; Choy JH J Inorg Biochem; 2008 Nov; 102(11):1991-6. PubMed ID: 18783832 [TBL] [Abstract][Full Text] [Related]
19. Nuclear Targeting with an Auger Electron Emitter Potentiates the Action of a Widely Used Antineoplastic Drug. Imstepf S; Pierroz V; Raposinho P; Bauwens M; Felber M; Fox T; Shapiro AB; Freudenberg R; Fernandes C; Gama S; Gasser G; Motthagy F; Santos IR; Alberto R Bioconjug Chem; 2015 Dec; 26(12):2397-407. PubMed ID: 26473388 [TBL] [Abstract][Full Text] [Related]
20. Mono- and dicationic Re(I)/(99m)Tc(I) tricarbonyl complexes for the targeting of energized mitochondria. Moura C; Mendes F; Gano L; Santos I; Paulo A J Inorg Biochem; 2013 Jun; 123():34-45. PubMed ID: 23507077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]